In a Q&A, Recursion’s incoming CEO acknowledges hype around the idea of using AI to expedite drug development, and says it's ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best mid cap stocks to buy according to hedge funds.

At ELRIG’s 2025 meeting in GSK’s Stevenage campus, Recursion’s Executive Director of Computational Biology, Dr. Kelly ...

Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...

Abstract: A method of data analysis based on data representation in the form of return recursion and recursive structures generated by it is considered. Problems to be solved: description of the ...

As we conversed in his office last month, Virginia Tech athletic director Whit Babcock envisioned future revenue streams for Hokies football such as corporate logos on uniforms and the field, ads ...

Investors probably won’t sweat this week’s inflation data as they fully pencil in a Federal Reserve rate cut following clear signs the labor market is slowing down. They shouldn’t take it too far. Fed ...

A galaxy proto-supercluster was discovered using VIMOS instrument of ESO’s Very Large Telescope. The astronomers who discovered it have nicknamed the bohemoth “Hyperion.” It has been visualized here.

I maintain a 'hold' rating on Recursion Pharmaceuticals due to mixed early-stage clinical data for FAP and uncertain pipeline progression. REC-617 showed an encouraging partial response in ...

Today, a brief rundown of news involving Insmed and Recursion Pharmaceuticals, as well as updates from Odyssey Therapeutics, Gilead Sciences and Novo Nordisk that you may have missed. Striking study ...